CD151—A Striking Marker for Cancer Therapy

Share this content:

the Cancer Therapy Advisor take:

Studies have shown cluster of differentiation 151 (CD151), a member of the mammalian tetraspanin family, is involved in various cellular functions such as angiogenesis, cell motility, cell-to-cell communication, maintaining normal cellular integrity, platelet aggregation, trafficking, and wound healing; however, overexpression of CD151 contributes to the invasion and metastasis of cancer cells through its interaction with α3β1 and α6β4 integrins via palmitoylation.

Of note, CD151 has been found to be highly expressed in tumors, such as breast, colon, and lung cancers, compared with non-solid tumors like Burkitt lymphoma, and high CD151 gene expression in cancer has been associated with poor prognosis, particularly in colon, endometrial, esophageal, lung, and pancreatic cancers.

The role of CD151 in cancer cell migration, invasion, and metastasis suggests that CD151 is an important target for cancer therapy.

Inhibiting CD151 may alter the signaling pathway involved in cancer cell survival and progression, thereby potentially halting tumor growth.

Possible strategies to target CD151 may include treatment with monoclonal antibodies, small hairpin RNA molecules, or gene knockout, and a better understanding of how palmitoylation affects the association of CD151 with integrins and non-integrin proteins may lead to new developments in cancer research.

Cluster of differentiation 151 (CD151) functions at various stages of cancer.
Cluster of differentiation 151 (CD151) functions at various stages of cancer.

ABSTRACT

Cluster of differentiation 151 (CD151) is a member of the mammalian tetraspanin family, which is involved in diverse functions such as maintaining normal cellular integrity, cell-to-cell communication, wound healing, platelet aggregation, trafficking, cell motility and angiogenesis. CD151 also supports de novo carcinogenesis in human skin squamous cell carcinoma (SCC) and tumor metastasis.

CD151 interacts with α3β1 and α6β4 integrins through palmitoylation where cysteine plays an important role in the association of CD151 with integrins and non-integrin proteins.

Invasion and metastasis of cancer cells were diminished by decreasing CD151 association with integrins. CD151 functions at various stages of cancer, including metastatic cascade and primary tumor growth, thus reinforcing the importance of CD151 as a target in oncology.

The present review highlights the role of CD151 in tumor metastasis and its importance in cancer therapy.


Keywords: CD151, integrins, metastasis, tetraspanin 

Insight on CD151 (Cluster of Differentiation 151)

Tetraspanins are four-transmembrane-spanning proteins with short cytoplasmic N- and C-termini and one small and one large extracellular domain, namely (EC1 and EC2), with a unique cysteine motif in EC2 domain.1

They are highly expressed on cell surface and/or intracellular vesicle. Palmitoylation of intracellular and juxtamembrane cysteine of tetraspanins along with specific integrins contributes to tetraspanin complex formation.

This complex formation protects tetraspanins from lysosomal degradation and promotes increased cell–cell interaction.2

CD151 (glycoprotein-27 (GP-27)/Red blood cell antigen MER 2 (MER 2)/platelet-endothelial tetraspan antigen-3 (PETA-3)/Raph blood group antigen (RAPH)/Membrane Glycoprotein SFA-1 (SFA-1)./tetraspanin-24 (TSPAN-24)) is a plasma membrane protein that belongs to tetraspanin superfamily.

CD151 forms tetraspanin web with integrins such as α3β1, α6β1, α7β1, and α6β4;2 membrane receptors; intracellular signaling molecules such as phosphoinositide 4-kinase (PI4K) and protein kinase C (PKC);3,4 immunoglobulin super family proteins and other tetraspanins such as CD9, CD81 and CD63. These tetraspanin-enriched microdomains (TEMs) serve as molecular facilitator.5

CD151 contains a potential tyrosine-based sorting motif in the C-terminal domain. The YXXφ (tyrosine linked with hydrophobic amino acid) motif (where φ is a hydrophobic residue) is required for endocytosis and sorting of proteins from the trans-Golgi network (TGN) to lysosomes for degradation. A mutation in the CD151 YXXφ motif diminishes CD151 internalization and affects integrin-dependent cell migration.6,7

The major functions of CD151 are maintenance of epithelial cell integrity, wound healing, platelet aggregation, regulation of membrane fusion, trafficking, cell motility, angiogenesis and tumor metastasis.8

It is normally expressed in endothelial cells and platelets and frequently overexpressed in cancer cells where it is functionally associated with cancer progression and metastasis.9

Page 1 of 7

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters